Abstract
Polycystic ovary syndrome (PCOS) is a very common endocrine disorder that has a strong genetic component and is characterized by polycystic ovaries, hyperandrogenemia, and menstrual irregularity. During the past decade, the roles of more than 70 candidate genes have been evaluated for a causal role in PCOS; however, because of genetic and phenotypic heterogeneity and underpowered studies, the results of many of these studies remain inconclusive. Here, the results of the genetic analysis of several candidate genes and gene regions—CYP11A (encoding cytochrome P450, family 11, subfamily A polypeptides), CAPN10 (encoding calpain 10), the insulin gene VNTR (variable number of tandem repeats), and D19S884 (a dinucleotide repeat marker mapping to chromosome 19p13.2)—are discussed in detail. Although past genetic studies of PCOS have yielded only modest results, resources and techniques have been assembled to remedy the major deficits of these early studies, promising that the next few years will be a very exciting and rewarding era for the genetic analysis of PCOS.
Key Points
-
Polycystic ovary syndrome (PCOS) is a very common endocrine disorder that has a large impact on the health burden of Western societies and that is believed to have a strong genetic basis
-
Dissection of the genetic basis of PCOS is currently an area of intensive investigation, with more than 70 genes that have been evaluated for their impact on the etiology of PCOS; however, to date, most studies have been underpowered and have yielded inconclusive, if not contradictory, results
-
The appropriate tools, including appropriately sized PCOS cohorts and genetic reagents, have now been assembled to carry out more suitable studies, promising that the next 10 years will be a very exciting and productive era in analysis of the genetic basis of PCOS
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Diamanti-Kandarakis E et al. (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84: 4006–4011
Knochenhauer ES et al. (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83: 3078–3082
Sam S and Dunaif A (2003) Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14: 365–370
Yildiz BO et al. (2003) Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88: 2031–2036
Sam S et al. (2005) Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 90: 4797–4802
Sir-Petermann T et al. (2002) Prevalence of type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia 45: 959–964
Yilmaz M et al. (2005) Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome. Hum Reprod (Oxf) 20: 2414–2420
Kiddy DS et al. (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 36: 105–111
Norman RJ et al. (2004) Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update 10: 267–280
Moran LJ et al. (2004) Short term energy restriction (using meal replacements) improves reproductive parameters in polycystic ovary syndrome. Asia Pacific J Clin Nutr 13 (Suppl): S88
Moran L and Norman RJ (2004) Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18: 719–736
Norman RJ et al. (2002) The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 13: 251–257
Cooper HE et al. (1968) Hereditary factors in Stein-Leventhal syndrome. Am J Obstet Gynecol 100: 371–387
Givens JR (1988) Familial polycystic ovarian disease. Endocrinol Metab Clin N Am 17: 771–783
Hague W et al. (1988) Familial polycystic ovaries: a genetic disease. Clin Endocrinol 29: 593–605
Ferriman D and Purdie AW (1979) The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol 11: 291–300
Carey AH et al. (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol 38: 653–658
Legro RS et al. (1998) Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A 95: 14956–14960
Kahsar-Miller M and Azziz R (1999) Heritability and the risk of developing androgen excess. J Steroid Biochem Mol Biol 69: 261–268
Jahanfar S et al. (1997) A twin study of polycystic ovary syndrome and lipids. Gynecol Endocrinol 11: 111–117
Kahsar-Miller MD et al. (2001) Prevalence of polycystic ovary syndrome (PCOS) in first degree relatives of patients with PCOS. Fertil Steril 75: 53–58
Vink J et al. (2005) Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 91: 2100–2104
Urbanek M et al. (1999) Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 96: 8573–8578
Escobar-Morreale HF et al. (2005) The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 26: 251–282
Newton-Cheh C and Hirschhorn JN (2005) Genetic association studies of complex traits: design and analysis issues. Mutat Res 573: 54–69
Hirschhorn JN (2005) Genetic approaches to studying common diseases and complex traits. Pediatr Res 57: 74R–77R
Hirschhorn JN and Daly MJ (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6: 95–108
Hattersley AT and McCarthy MI (2005) What makes a good genetic association study? Lancet 366: 1315–1323
Zawadzki JK and Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Polycystic Ovary Syndrome, 377–384 (Eds Dunaif A et al.) Boston: Blackwell Scientific
The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41–47
Altshuler D et al. (2000) The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26: 76–80
Grant SF et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320–323
Gharani N et al. (1997) Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 6: 397–402
Diamanti-Kandarakis E et al. (2000) Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11α influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil Steril 73: 735–741
Daneshmand S et al. (2002) Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17α-hydroxylase/C(17-20) lyase promoters. Fertil Steril 77: 274–280
San Millan JL et al. (2001) Role of the pentanucleotide (tttta)(n) polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertil Steril 75: 797–802
Gaasenbeek M et al. (2004) Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab 89: 2408–2413
Bell GI et al. (1982) The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences. Nature 295: 31–35
Pugliese A and Miceli D (2002) The insulin gene in diabetes. Diabetes Metab Res Rev 18: 13–25
Waterworth DM et al. (1997) Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 349: 986–990
Michelmore K et al. (2001) Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight. Clin Endocrinol (Oxf) 55: 439–446
Calvo RM et al. (2002) Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women. Fertil Steril 77: 666–668
Powell BL et al. (2005) Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. J Clin Endocrinol Metab 90: 2988–2993
Hanis CL et al. (1996) A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13: 161–166
Horikawa Y et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163–175
Evans JC et al. (2001) Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 69: 544–552
Tsai HJ et al. (2001) Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am J Hum Genet 69: 1236–1244
Ehrmann DA et al. (2002) Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87: 1669–1673
Haddad L et al. (2002) Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. J Clin Endocrinol Metab 87: 2606–2610
Urbanek M et al. (2005) Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab 90: 6623–6629
Tucci S et al. (2001) Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor locus. J Clin Endocrinol Metab 86: 446–449
Villuendas G et al. (2003) Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome. Fertil Steril 79: 219–220
Hata R et al. (2000) Association of functional microsatellites in the human type I collagen α2 chain (COL1A2) gene with systemic sclerosis. Biochem Biophys Res Commun 272: 36–40
Fenech AG et al. (2004) Novel polymorphisms influencing transcription of the human CHRM2 gene in airway smooth muscle. Am J Respir Cell Mol Biol 30: 678–686
Huang TS et al. (2003) Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression. Biochem Biophys Res Commun 300: 901–907
Gabellini N (2001) A polymorphic GT repeat from the human cardiac Na+Ca2+ exchanger intron 2 activates splicing. Eur J Biochem 268: 1076–1083
Hui J et al. (2003) HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats. Nat Struct Biol 10: 33–37
Abbott DH et al. (2002) Developmental origin of polycystic ovary syndrome—a hypothesis. J Endocrinol 174: 1–5
Abbott DH et al. (2005) Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 11: 357–374
Foecking EM et al. (2005) Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator. Biol Reprod 72: 1475–1483
de Zegher F et al. (2006) Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome. Fertil Steril 86: S4
Ibanez L et al. (2002) Reduced ovulation rate in adolescent girls born small for gestational age. J Clin Endocrinol Metab 87: 3391–3393
Ibanez L et al. (2002) Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism. J Clin Endocrinol Metab 87: 5702–5705
Ibanez L et al. (2001) Polycystic ovary syndrome after precocious pubarche: ontogeny of the low birthweight effect. Clin Endocrinol 55: 667–672
Ibanez L et al. (2006) Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational age children. J Clin Endocrinol Metab 91: 2153–2158
Hickey TE et al. (2006) Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab 91: 2789–2791
Mhatre AN et al. (1993) Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet 5: 184–188
Tut TG et al. (1997) Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82: 3777–3782
Jakubiczka S et al. (1997) Mutations of the androgen receptor gene in patients with complete androgen insensitivity. Hum Mutat 9: 57–61
Jaaskelainen J et al. (2005) Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome. Fertil Steril 83: 1724–1728
Legro R et al. (1994) Size polymorphisms of the androgen receptor among female Hispanics and correlation with androgenic characteristics. Obstet Gynecol 83: 701–706
Mifsud A et al. (2000) Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. J Clin Endocrinol Metab 85: 3484–3488
Mohlig M et al. (2006) The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. Eur J Endocrinol 155: 127–130
Hickey T et al. (2002) The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab 87: 161–165
The International HapMap Consortium (2003) The International HapMap Project. Nature 426: 789–796
Altshuler D et al. (2005) A haplotype map of the human genome. Nature 437: 1299–1320
Pasternack JJ (1999) Discovering human disease genes. In An Introduction to Human Molecular Genetics, 218–219 (Ed. Pasternack JJ) Bethesda, MD: Fitzgerald Science Press
Metzker ML (2005) Emerging technologies in DNA sequencing. Genome Res 15: 1767–1776
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Urbanek, M. The genetics of the polycystic ovary syndrome. Nat Rev Endocrinol 3, 103–111 (2007). https://doi.org/10.1038/ncpendmet0400
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0400
This article is cited by
-
Understanding polycystic ovary syndrome in light of associated key genes
Egyptian Journal of Medical Human Genetics (2023)
-
Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats
Nutrire (2023)
-
Effects of ADIPOQ polymorphisms on PCOS risk: a meta-analysis
Reproductive Biology and Endocrinology (2018)
-
Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance
Journal of Assisted Reproduction and Genetics (2016)
-
PCOS in Adolescence and Type 2 Diabetes
Current Diabetes Reports (2015)